We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

TriLink BioTechnologies Launches mitoPrimers™ for mtDNA Analysis

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The high sensitivity of mitochondrial DNA (mtDNA) PCR amplification and sequencing allows forensic scientists to obtain information from items of evidence associated with homicides or other criminal investigations, body identifications, cold cases and small pieces of evidence containing little biological material.

Standard mitoPrimers™ are now available from TriLink as stocked inventory in convenient pre-aliquotted dilute-and-go vials. TriLink's mitoPrimers™ are QC tested with certified standard reference materials. These features allow less in-house testing to assure quality by the end user. TriLink is the only commercial source of these QC tested primers, and also offers custom synthesis of other forensic mtDNA PCR amplification and sequencing primers and forensic mtDNA single-nucleotide polymorphism (SNP) assay primers.

"After learning from our customers that the high quality primers required in this extremely sensitive work were challenging to find in the market, we decided to invest in this area. With the expert advice of leading forensic scientist, Rhonda Roby we developed mitoPrimers™. We are excited to have the opportunity to support mtDNA forensic analysis and will soon be releasing a mastermix product that will significantly improve the mtDNA PCR-sequencing workflow," stated TriLink CEO, Richard Hogrefe, Ph.D.

"We routinely use TriLink's mitoPrimers™ in our mitochondrial research," said Dr. Rhonda Roby, Associate Professor of Forensic and Investigative Genetics at UNT Health Science Center. "We've found them to be both cost-effective and convenient."